ACADIA Pharmaceuticals Inc. (LON:0A4W)

ACADIA Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,419	2,439	4,036	2,140	2,771	6,225
Market Cap Growth	51.22%	-39.57%	88.62%	-22.79%	-55.49%	25.12%
Enterprise Value	2,832	2,027	3,809	1,830	2,421	5,789
Last Close Price	20.16	14.63	24.82	13.03	17.82	39.26
PE Ratio	17.60	13.48	-	-	-	-
PS Ratio	4.39	3.19	7.08	4.98	7.75	19.24
PB Ratio	5.01	4.17	11.91	6.44	6.94	13.56
P/TBV Ratio	5.70	4.98	14.04	6.44	6.94	13.58
P/FCF Ratio	23.24	19.42	308.70	-	-	-
P/OCF Ratio	23.10	19.36	307.78	-	-	-
EV/Sales Ratio	3.65	2.65	6.68	4.26	6.77	17.89
EV/EBITDA Ratio	31.55	25.33	-	-	-	-
EV/EBIT Ratio	40.46	30.11	-	-	-	-
EV/FCF Ratio	19.24	16.14	291.36	-	-	-
Debt / Equity Ratio	0.06	0.07	0.13	0.16	0.12	0.08
Debt / EBITDA Ratio	0.45	0.47	-	-	-	-
Debt / FCF Ratio	0.28	0.33	3.44	-	-	-
Asset Turnover	0.91	0.99	1.09	0.80	0.65	0.56
Inventory Turnover	9.53	13.33	18.53	51.22	29.44	35.81
Quick Ratio	2.77	2.18	2.13	3.82	6.10	6.44
Current Ratio	3.02	2.38	2.42	4.04	6.43	6.77
Return on Equity (ROE)	34.95%	38.89%	-14.73%	-45.89%	-28.75%	-42.47%
Return on Assets (ROA)	5.11%	5.44%	-6.86%	-21.70%	-14.37%	-18.66%
Return on Capital (ROIC)	7.38%	8.27%	-9.64%	-26.18%	-16.62%	-21.09%
Return on Capital Employed (ROCE)	9.70%	10.60%	-14.80%	-48.40%	-28.20%	-34.60%
Earnings Yield	5.68%	7.42%	-1.19%	-8.38%	-4.47%	-3.31%
FCF Yield	4.30%	5.15%	0.32%	-4.42%	-3.38%	-1.69%
Buyback Yield / Dilution	-1.70%	-1.55%	-1.32%	-0.74%	-2.01%	-6.88%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.